National
Lesbian who fought workplace discrimination ‘honored’ to attend SOTU
Kilker to join handful of guests in first lady’s box
Lorelei Kilker (left) with her partner Sara Nelson (photo courtesy Kilker)
The invitation to witness the State of the Union address on Tuesday alongside first lady Michelle Obama came as a surprise to a lesbian analytical chemist who last year fought alleged workplace sex discrimination.
In an interview with the Washington Blade, Lorelei Kilker, 31, of Brighton, Colo., said she learned she was invited to attend the speech upon receiving a call from a White House official on Sunday.
“It was a Sunday and the middle of the day,” she said with a laugh. “They left a message on my phone from someone who said, ‘This is the White House.’ I was very shocked. I didn’t think that anything like this would happen. I was honored and shocked.”
One of a handful of guests that have been selected to sit in the first lady’s box in the House gallery, Kilker will watch President Obama deliver his speech at 9 p.m. before a joint session of Congress.
Kilker described the feeling of being able to sit next to first lady Michelle Obama to watch the president as he gives his speech as “overwhelming.”
“You see the president and you see the first lady on TV,” Kilker said. “You recognize them, but I never in a million years would have thought I would have the opportunity to see them in person. It’s pretty great.”
Kilker said she’ll be traveling to D.C. with her partner of three-and-a-half years, Sarah Nelson, who’s 33 and works at Dick’s Sporting Goods. They have two children, ages four and seven. However, Kilker will be attending the speech on her own.
The message that Kilker hopes to hear from President Obama on Tuesday night: “getting America back together, becoming united.”
Asked whether she’d like to hear something from Obama on LGBT issues, such as an endorsement of same-sex marriage, Kilker replied, “I think that that’s important. There have been steps, but we need something stronger.”
What would Kilker want to say to Michelle Obama if they have an opportunity to chat? Kilker said she’d commend the first lady for being an admirable person.
“The only thing I would say to her is that I think she’s a positive and strong female role model, and the Obama administration has done a lot for civil rights as opposed to other administrations,” Kilker said.
Kilker was invited to attend the State of the Union address after she received monetary relief in an Equal Employment Opportunity Commission case that investigated alleged sex discrimination she faced at while employed at the Western Sugar Cooperative.
According to an EEOC statement from when the case was resolved in October, EEOC found Western Sugar denied women training and promotions, gave them less desirable work assignments and segregated positions by gender at its Ft. Morgan, Colo., facility. Additionally, the company allegedly denied year-round employment and paid lower wages to women.
Western Sugar has denied any wrongdoing and maintains it’s an equal opportunity employer, but agreed to resolve the matter through EEOC’s reconciliation process.
But Kilker contends that women “had certain jobs they were allowed to have, and there were certain jobs that they were not allowed to have.”
“The jobs that women had were mediocre, they paid less,” Kilker said. “There was really no opportunity for advancement. The male jobs were higher-wage, promotions, things like that.”
When she tried to enter one of these “male jobs,” Kilker said she was repeatedly denied the opportunity despite her record.
“The management would come up to me and promise me that they were going to do this, they were going to do this,” Kilker said. “Then, they would go back and say, ‘No we’re not going to do this. No we’re not going to this. We changed our mind.”
Additionally, Kilker said management at the company singled her out for sexual harassment that made her “working life miserable” until she eventually quit her job.
“My family received phone calls saying that I was doing sexual activities in order to do jobs, and things like that,” Kilker said. “It got pretty disgusting.”
Kilker said the discrimination she faced was the result of her gender and not her sexual orientation. She said she doesn’t believe her former employer knew she was a lesbian.
On the grounds that the alleged discrimination was in violation of Title VII of the Civil Rights Act of 1964, Kilker filed charges on behalf of herself and other women at the company.
As a result of arrangements that were achieved through a cooperative process between the employer and EEOC, Kilker and others involved in the class-action case received $550,000 in relief. Further, Western Sugar agreed to remedial relief such as training for all employees and appointed an internal representative who’ll report to the EEOC to monitor the company’s employment practices for the next three years.
Kilker said she received “the majority share” of the $550,000, although she couldn’t recall the exact portion of that amount she received.
“I was so happy,” Kilker. “It had taken so many years that I just had kind of gotten to the point where I was over it. And then, the investigator at the EEOC really got into it, and it was just amazing how far they came with that.”
According to the White House, EEOC has obtained almost $50 million in monetary relief through administrative enforcement for victims of sex-based wage discrimination since the creation of the President’s Equal Pay Task Force in January 2010. Additionally, EEOC obtained changes to workplace practices that benefit more than 250,000 workers, and filed five cases including sex-based wage discrimination claims.
Although EEOC was able to resolve the issue, Kilker said more advancements are necessary to protect workers against discrimination.
Kilker said she supports the idea of Obama taking action administratively to bar discrimination in the workplace. Some LGBT rights advocates have urged the president to issue an executive order preventing federal dollars from going to companies without LGBT-inclusive workplace non-discrimination protections.
“I think that’s a great idea,” Kilker said. “It’s just another step in the right direction, and that’s what we need.”
But Kilker won’t be the only LGBT person attending the State of the Union. The other lesbian invitee is Air Force Col. Ginger Wallace, who’s 43 and lives in McLean, Va. She’s currently training to deploy to Afghanistan in the spring through the Afghanistan-Pakistan Hands program.
The Washington Blade reported in December on Wallace’s partner Kathy Knopf participating in her “pinning-on” promotion ceremony, the first reported instance of such an event happening with a same-sex partner since the lifting of “Don’t Ask, Don’t Tell.”
On Tuesday, Wallace told the Blade that she and her partner are “honored and humbled” to represent LGBT people and families who’ve served in the armed forces.
“We’re just amazed that we were chosen to do that,” Wallace said. “We’re just humbled to represent this unique section of people. There are really are a lot of exceptional gays and lesbians who serve in our military.”
If she has an opportunity to speak with Michelle Obama, Wallace said she’d thank the first lady — as well as second lady Jill Biden — for their work leading the national campaign called “Joining Forces,” which was launched in April to support military families through public service outreach and partnerships.
“They have worked tirelessly to increase support for military families, ensure that military families are taken care of,” Wallace said. “That’s important work, especially today. After 10 years of conflict, 10 years of deployment — that’s taken its toll.”
Wallace said she hopes Obama during his speech will the end of “Don’t Ask, Don’t Tell” as one of the accomplishments of his administration.
“I hope it is highlighted as a success, and I think, more importantly, I hope it is received by the audience as a success,” Wallace said. “I hope this is seen as the success I think the administration thinks it is.”
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
Child- and pet-proofing your home for the holidays
‘Dogs of Venice’ looks at love lost and rediscovered
A Wider Bridge to close
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
Rehoboth’s Blue Moon is for sale but owners aim to keep it in gay-friendly hands
LGBTQ Democrats say they’re ready to fight to win in 2026
Brian Footer suspends campaign for Ward 1 D.C. Council seat
Lighting candles in a time of exhaustion
2026 elections will bring major changes to D.C. government
Kazakh Senate approves anti-LGBTQ propaganda bill
-
Politics4 days agoLGBTQ Democrats say they’re ready to fight to win in 2026
-
District of Columbia4 days ago
Brian Footer suspends campaign for Ward 1 D.C. Council seat
-
Opinions4 days ago
Lighting candles in a time of exhaustion
-
Opinions3 days ago
2026 elections will bring major changes to D.C. government
